2005 News Archive
Please browse our press releases below. These are all in Adobe Acrobat PDF format. If you do not have an appropriate PDF reader, please click here
In-licensing of European Rights to Rapinyl and Pre-close period Trading Update
ProStrakan re-negotiates improved EU rights to Rectogesic
Interim Results for the six months ended 30 June 2005
First medicine licensed specifically for the relief of chronic anal fissure pain launched in UK
Announcement of indicative value range of £160 million to £190 million
Acquisition of APS Pharma GmbH expands ProStrakan's European sales & marketing operation
ProStrakan appoints former AstaZeneca VP of Global Licensing as Non-Executive Director
